A new study shows that the Shingles vaccine may offer more than just protection from painful rashes—it could also reduce the risk of dementia. Researchers at Stanford University have found a potential link between the vaccine and a 20% decrease in dementia diagnoses, based on a detailed analysis of UK health data.
Shingles Vaccine Shows Promise in Dementia Prevention
Published in Nature, the study examined individuals in Wales, UK, where eligibility for the Shingles vaccine was determined solely by birthdate. Those born just after September 2, 1933, were eligible, while those born just before were not. This rare policy feature created a natural experiment that allowed researchers to compare similar individuals with and without vaccine access.
Over a seven-year follow-up, researchers observed a 3.5 percentage point reduction in dementia diagnoses among eligible individuals, translating to a 20% relative risk reduction.
Stronger Impact Observed in Women
The effect of the Shingles vaccine was notably stronger in women, where statistical significance was reached. In men, results were less definitive due to wider confidence intervals. Interestingly, the reduction in dementia risk became evident more than a year after vaccination, suggesting longer-term immune-related changes might be at play.
Possible Immune Benefits of Shingles Vaccination
While the Shingles vaccine is primarily used to prevent the varicella-zoster virus from reactivating, it may also reduce neuroinflammation—one of the factors linked to dementia. Scientists suggest that live-attenuated vaccines like the one used in this study might boost immune responses in a way that offers indirect brain protection.
Study Based on Zostavax, Not Shingrix
The findings are specific to the live-attenuated Shingles vaccine, Zostavax. The recombinant vaccine Shingrix, now more commonly used, was not included in this study. Future research is needed to determine if it provides similar cognitive benefits.
Shingles Vaccine Could Be a Cost-Effective Preventive Tool
With dementia continuing to rise globally and no definitive cure, this study points to this vaccine as a potential low-risk, cost-effective method for prevention. Already widely available for preventing Shingles, this vaccine may also hold unexpected promise in supporting cognitive health.
For more information: Eyting, M., Xie, M., Michalik, F. et al. (2025). A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. DOI:10.1038/s41586-025-08800-x https://www.nature.com/articles/s41586-025-08800-x
more recommended stories
Obesity-Associated Leukemia Linked to InflammationKey Takeaways Researchers identified how obesity.
Chronic Xanthan Gum Alters Gut Microbiota and Colon HealthKey Points Chronic xanthan gum consumption.
Calcific Aortic Valve Stenosis Linked to Gum Disease BacteriaKey Points Researchers identified a potential.
Drug Delivery Nanoparticles Studied with New AF4-SANS ToolKey Points Researchers developed the first.
Gut-Friendly Diet Linked to Lower CHD Mortality RiskKey Summary A higher Dietary Index.
Parkinson’s Disease Risk Linked to Short Sleep, Study FindsKey Points A large Chinese cohort.
Cancer Risk And Allergic Diseases Linked in New StudyKey Points A large meta-analysis of.
Lifestyle Behaviors and Mood Linked in Daily Life StudyKey Points A 70-day diary study.
Cat Fleas Linked to Murine Typhus Risk in Texas StudyKey Points Researchers detected Rickettsia typhi.
Pediatric Surgical Safety Reduces Serious Surgical EventsKey Points Pediatric operating room safety.
Leave a Comment